Skip to main content
. 2020 Jan 21;2020:2594702. doi: 10.1155/2020/2594702

Table 1.

Demographic-, psycho-socio-economical-, and MS-related data.

Without ST and SI
0
With ST
1
With SI
2-3
Gender
Female 213-67.9% 9-52.9% 15-83.3%
Male 101-32.2% 8-47.1% 3-16.7%
Age (mean/SD) 42.85/9.75 42.59/8.91 45.5/8.71
Disease duration
Median (min–max) 10 (0-39) 10 (2-28) 11 (7-34)
Type of MS
CIS 10-3.2% 0-0.0% 0-0.0%
RRMS 224-71.3% 11-64.7% 10-55.6%
SPMS 80-25.5% 6-35.3% 8-44.4%
Treatment duration
Median (min–max) 7 (0-15) 9 (1-14) 7.5 (3-13)
Type of treatment
AVONEX 44-14% 3-17.6% 0-0.0%
BETAFERON 121-38.5% 7-41.2% 9-50%
COPAXONE 58-18.5% 2-11.8% 6-33.3%
REBIF 78-24.8% 2-11.8% 3-16.7%
TYSABRI 13-4.1% 3-17.6% 0-0.0%
EDSS
Median (min–max) 2.5 (0-8.5) 4 (1.5-8) 3.25 (1-7)
Number of relapses
Median (min–max) 4 (0-24) 5 (1-32) 5.5 (1-15)
Marital status
Married/living with partner 210-67.1% 9-52.9% 14-77.8%
Single 68-21.7% 5-29.4% 3-16.7%
Divorced 23-7.3% 3-17.6% 1-5.6%
Widow 12-3.8% 0-0.0% 0-0.0%
Educational level
Elementary school 9-2.9% 0-0.0% 4-22.2%
Apprentice school 54-17.3% 4-23.5% 5-27.8%
High school 119-38% 7-41.2% 6-33.3%
University 96-30.7% 6-35.3% 2-11.1%
Master or PhD 22-7.0% 0-0.0% 1-5.6%
Technical and vocational high school 13-4.2% 0-0.0% 0-0.0%
Occupational status
Employed 125-39.9% 6-35.3% 4-22.2%
Part-time employed 20-6.4% 1-5.9% 1-5.6%
Disability pension 140-44.7% 10-58.8% 13-72.2%
Retired 8-2.6% 0-0.0% 0-0.0%
Student 2-0.6 0-0.0% 0-0.0%
Unemployed 17-5.4% 0-0.0% 0-0.0%